메뉴 건너뛰기




Volumn 19, Issue 18, 2011, Pages 5490-5499

2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3, 4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A

Author keywords

DPP IV inhibitors; Mechanism based inactivation

Indexed keywords

2 [[6 (3 AMINO 3 METHYLPIPERIDINE 1 YL) 1,3 DIMETHYL 2,4 DIOXO 1,2,3,4 TETRAHYDRO 5H PYRROLO [3,2 D] PYRIMIDINE 5 YL]METHYL] 4 FLUOROBENZONITRILE; CYTOCHROME P450 3A; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DSR 12727; GLUCOSE; PEPTIDASE; UNCLASSIFIED DRUG;

EID: 80052571269     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2011.07.042     Document Type: Article
Times cited : (24)

References (43)
  • 1
    • 67651239262 scopus 로고    scopus 로고
    • S.R. Colberg ACSM'S Health Fitness J. 12 2008 16 For latest information, please see the website of World Health Organization at http://www.who.int/ diabetes/facts/world-figures/en/
    • (2008) ACSM'S Health Fitness J. , vol.12 , pp. 16
    • Colberg, S.R.1
  • 4
    • 31844443202 scopus 로고    scopus 로고
    • For some references, see: J.J. Holst Diabetologia 49 2006 253
    • (2006) Diabetologia , vol.49 , pp. 253
    • Holst, J.J.1
  • 21
    • 80052585275 scopus 로고    scopus 로고
    • World Patent 2004048379
    • Nakahira, H.; Hochigai, H. World Patent 2004048379, 2004
    • (2004)
    • Nakahira, H.1    Hochigai, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.